Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance-Reference-Cited by-同舟云学术

Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance

Published:2006-10 Issue:4 Volume:10 Page:331-342
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Wei Guo,Twomey David,Lamb Justin,Schlis Krysta,Agarwal Jyoti,Stam Ronald W.,Opferman Joseph T.,Sallan Stephen E.,den Boer Monique L.,Pieters Rob,Golub Todd R.,Armstrong Scott A.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference61 articles.

1. Inhibition of glucocorticoid-induced apoptosis by targeting the major splice variants of BIM mRNA with small interfering RNA and short hairpin RNA;Abrams;J. Biol. Chem.,2004

2. Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification;Armstrong;Cancer Cell,2003

3. Dexamethasone resistance in B-cell precursor childhood acute lymphoblastic leukemia occurs downstream of ligand-induced nuclear translocation of the glucocorticoid receptor;Bachmann;Blood,2005

4. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity;Bouillet;Science,1999

5. Gene expression determinants of clinical outcome;Buckhaults;Curr. Opin. Oncol.,2006

Cited by 453 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IKZF1 in acute lymphoblastic leukemia: the rise before the fall?;Leukemia & Lymphoma;2024-08-29

2. Discovery of a Myeloid Cell Leukemia 1 (Mcl-1) Inhibitor That Demonstrates Potent In Vivo Activities in Mouse Models of Hematological and Solid Tumors;Journal of Medicinal Chemistry;2024-08-05

3. Dual targeting of histone deacetylases and MYC as potential treatment strategy for H3-K27M pediatric gliomas;eLife;2024-08-02

4. Dual targeting of histone deacetylases and MYC as potential treatment strategy for H3-K27M pediatric gliomas;eLife;2024-08-02

5. Dual Targeting of Histone Deacetylases and MYC as Potential Treatment Strategy for H3-K27M Pediatric Gliomas;2024-07-04